DSPS is a circadian rhythm disorder where the entire sleep-wake cycle is phase-delayed — the patient naturally falls asleep at 2–4 AM and wakes at 10 AM–12 PM, feeling perfectly rested on this schedule but unable to fall asleep “on time.” It affects an estimated 0.17% of adults and is heavily genetic (CLOCK gene variants). It is often misdiagnosed as insomnia or depression.
For DSPS, melatonin taken 5–6 hours before the desired sleep time (often around 8–9 PM) phase-advances the circadian clock by approximately 1–1.5 hours per day when combined with bright light exposure in the morning (10,000 lux for 30 minutes at the target wake time). The combination of evening melatonin plus morning bright light is far more effective than either alone, with complete DLMO normalization in 3–6 weeks in most patients.
Shift Work Sleep Disorder
Shift workers who work nights have 40% higher rates of cardiovascular disease, 30% higher rates of metabolic syndrome, and significantly elevated cancer risk — all related to chronic circadian disruption rather than sleep quantity alone. Melatonin taken before daytime sleep (after a night shift) improves daytime sleep duration by approximately 24 minutes per the best available meta-analyses — a modest but consistent benefit. Blackout curtains and avoiding light exposure during the commute home (blue-light blocking glasses) amplify the melatonin effect.
Insomnia in Older Adults
Melatonin production declines approximately 50% between ages 40 and 70, with the DLMO signal also blunting with age. The reduction is partly due to pineal gland calcification, reduced B6 cofactor status (B6 is required for serotonin-to-melatonin conversion), and increased light sensitivity of the MT receptors. For adults over 60 with insomnia, prolonged-release melatonin (PR-melatonin, 2 mg) — which mimics the extended nocturnal melatonin profile — has the strongest evidence: a Cochrane review found PR-melatonin significantly improved sleep quality, reduced sleep onset latency, and was well-tolerated without next-day impairment or withdrawal effects.
The Light Exposure Framework: What Controls Melatonin More Than Supplements
The most powerful melatonin intervention is not a supplement — it is light management. Blue wavelength light (460–480 nm) maximally suppresses melatonin via melanopsin activation in ipRGCs. Typical indoor lighting at night delivers 10–50 lux; smartphones and computer screens deliver 50–500 lux of heavily blue-shifted light. Exposure to even 8 lux of light containing blue wavelengths in the 2–3 hours before bed measurably delays melatonin onset.
The practical protocol for melatonin optimization without supplementation: bright light exposure within 30 minutes of waking (outdoor is best; 10,000 lux light box if outdoor is not available), no overhead fluorescent or cool-white LED light after 9 PM, amber-spectrum bulbs or candlelight in the bedroom, and no screen use within 60 minutes of target sleep time (or blue-light blocking glasses rated to 480 nm). This protocol reliably advances DLMO by 30–90 minutes in people with artificially delayed circadian timing — essentially treating mild DSPS without any supplement.
Sleep deprivation suppresses immune function after just one night — even moderate restriction to 6 hours doubles cold susceptibility. Melatonin production is also directly tied to temperature: the body needs to drop 1–2°F for optimal pineal activation, which is why a cool bedroom (65–68°F) is consistently associated with better sleep quality and higher melatonin output.
Melatonin and Cortisol: The Day-Night See-Saw
Melatonin and cortisol are reciprocally regulated. As melatonin rises in the evening, it suppresses the HPA axis and cortisol secretion. As cortisol rises in the early morning (the cortisol awakening response, or CAR), it suppresses melatonin. This reciprocal relationship means that chronic HPA axis activation — from psychological stress, poor diet, or insufficient sleep — directly suppresses melatonin production and delays sleep onset.
The most common cause of difficulty falling asleep at 10–11 PM with an overactive mind is elevated evening cortisol — not melatonin deficiency. In this context, taking 5 mg melatonin will not overcome elevated cortisol activity. The correct intervention is cortisol-lowering (ashwagandha KSM-66, phosphatidylserine, magnesium glycinate) combined with the light management protocol above. Melatonin supplementation then works far better against a lower cortisol background.
The Complete Sleep Supplement Stack: Beyond Melatonin
Melatonin addresses circadian timing. For sleep architecture (specifically slow-wave sleep depth and REM quality), the following compounds have the strongest evidence:
Magnesium glycinate (300–400 mg, 60 minutes before bed): Magnesium is a cofactor for GABA-A receptor function and directly inhibits NMDA receptors, producing the quiet-nervous-system effect required for sleep onset. A 2012 RCT of 46 older adults found magnesium supplementation significantly improved sleep efficiency, sleep time, and early morning awakening scores versus placebo. It also reduces cortisol and elevates melatonin levels — addressing two upstream drivers simultaneously. Glycinate form is preferred (chelated to glycine, itself a glycine receptor agonist with sleep-deepening effects).
L-theanine (200 mg): An amino acid from green tea that increases alpha brain wave activity (associated with relaxed wakefulness) and elevates GABA and glycine. A 2019 RCT found 200 mg L-theanine 60 minutes before bed improved sleep efficiency, sleep quality, and next-morning alertness without sedation. It works via a completely different mechanism than melatonin and stacks well.
Ashwagandha KSM-66 (300–600 mg): The best-evidenced adaptogen for sleep. A 2019 double-blind RCT published in Medicine found KSM-66 significantly improved total sleep time, sleep efficiency, sleep onset latency, and sleep quality versus placebo over 10 weeks. The mechanism is HPA axis suppression (reducing cortisol) combined with triethylene glycol, a specific withanolide shown to induce sleep in animal models via GABA receptor modulation. It also reduces cortisol — the upstream driver of sleep disruption.
Glycine (3–5 g): An amino acid that reduces core body temperature by causing peripheral vasodilation — one of the key physiological triggers for sleep onset. A 2012 Japanese study found 3 g glycine before bed reduced sleep onset latency, improved slow-wave sleep, and reduced daytime sleepiness the following day. Inexpensive (glycine powder, approximately $15–20 for a 3-month supply), tasteless, and safe. This is one of the most underutilized sleep supplements.
Phosphatidylserine (200–400 mg): A phospholipid that blunts ACTH-driven cortisol production and specifically reduces exercise-induced and psychological stress-induced cortisol spikes. Particularly useful for people whose sleep disruption is driven by high cortisol (rumination, anxiety, 3 AM awakenings after stressful days). When chronic stress is activating the HPA axis, no amount of melatonin will fully compensate without cortisol attenuation.
Melatonin Safety: What You Need to Know
Melatonin is exceptionally safe in short-term use. It does not cause respiratory depression (unlike benzodiazepines), has no addiction potential, and produces no withdrawal syndrome. The most common side effects at high doses (5–10 mg) are next-day grogginess (“sleep inertia”), vivid dreams, and mild headache — all dose-dependent and resolved by reducing to 0.5–1 mg.
The long-term safety question is more nuanced. Exogenous melatonin at pharmacological doses may suppress endogenous pineal production — the same feedback mechanism that suppresses any hormone when you supplement it externally. The evidence is inconsistent: some studies show endogenous suppression with chronic high-dose use; others do not. The conservative approach is to use physiological doses (0.5–1 mg) and reserve melatonin for specific circadian applications (jet lag, shift work, occasional sleep schedule correction) rather than nightly indefinite use. For nightly sleep support, the GABA and cortisol-modulating stack above is more appropriate for long-term use.
Drug interactions: melatonin may potentiate the effects of sedative medications and should be used cautiously with anticoagulants (warfarin) due to theoretical interaction with platelet aggregation pathways. Immunosuppressed patients (organ transplant recipients) should consult their physician before using melatonin, as it has documented immunomodulatory effects.
Melatonin in Children: A Special Note
Pediatric melatonin use has increased 530% in the US between 2012 and 2021 (JAMA Pediatrics, 2023). This is concerning for several reasons. Children have robust endogenous melatonin production; most pediatric sleep problems are behavioral (inconsistent bedtime, screen exposure, insufficient physical activity) rather than physiological. The pediatric pineal gland is highly sensitive to exogenous melatonin, and long-term safety data in children is sparse. The 2023 JAMA Pediatrics study found that many pediatric melatonin products contained doses far exceeding the label — one product contained 347% of the labeled dose.
For children with neurodevelopmental conditions (autism spectrum disorder, ADHD) — where melatonin timing mechanisms are genuinely dysregulated — short-term use at pediatric doses (0.5–3 mg) under physician supervision has reasonable evidence. For neurotypical children with sleep difficulties, behavioral sleep interventions (consistent schedule, no screens 60 minutes before bed, cool dark room, sufficient physical activity) should be exhausted before any supplementation.
The Bottom Line
Melatonin is a genuine and effective circadian intervention — but it is widely misused. The 5–10 mg doses that dominate the US market are pharmacologically excessive; 0.5–1 mg is the evidence-based starting dose for phase-shifting. The best use cases are jet lag, shift work adaptation, delayed sleep phase syndrome, and age-related melatonin decline in adults over 55. For general sleep quality, addressing light exposure, cortisol dysregulation, and magnesium status will outperform melatonin supplementation in most people.
Sleep is the single highest-leverage health intervention available. A night of 7–9 hours with proper sleep architecture — specifically adequate slow-wave sleep and REM cycling — restores immune function, consolidates memory, clears amyloid from the brain via the glymphatic system, and resets the HPA axis for the following day. No supplement fully compensates for structural sleep disruption. If you have persistent difficulty sleeping despite implementing these strategies, contact our office at (810) 206-1402 for a full sleep and circadian assessment.
Frequently Asked Questions
What is the best dose of melatonin for sleep?
For circadian phase-shifting (jet lag, DSPS, shift work), 0.5–1 mg taken 60–90 minutes before the desired bedtime is the evidence-based dose. For older adults with insomnia, prolonged-release melatonin 2 mg has the strongest clinical trial data. The 5–10 mg doses sold in most US supplements are pharmacologically excessive — they do not produce greater sleep benefit than 1 mg but increase next-day grogginess and may suppress endogenous production with chronic use.
Can you take melatonin every night?
Short-term nightly use (2–4 weeks) is safe and well-tolerated. For long-term nightly use, the evidence is limited. The conservative approach is to use melatonin for specific circadian applications (jet lag, schedule correction) and use a GABA/cortisol-modulating stack (magnesium glycinate, L-theanine, ashwagandha) for ongoing sleep support. There is no strong evidence of harm with chronic low-dose (0.5–1 mg) use, but high-dose chronic use may suppress endogenous production.
Why do I wake up at 3 AM even after taking melatonin?
3 AM awakening is a classic sign of premature cortisol surge — the HPA axis activating hours before it should, typically triggered by overnight blood sugar dropping (cortisol is a counter-regulatory hormone), chronic stress, gut dysbiosis, or HPA axis hyperactivity. Melatonin addresses sleep onset but does not prevent cortisol-driven early awakenings. The correct intervention is phosphatidylserine before bed, stable blood sugar overnight (avoid alcohol, eat a small protein snack if needed), and addressing the upstream stress load.
Does melatonin help with anxiety?
Melatonin has mild anxiolytic effects via MT1 receptor activity in the amygdala and suppression of the circadian alerting signal. However, for anxiety-driven sleep disruption, direct GABA modulators (L-theanine, magnesium glycinate) and cortisol-attenuating agents (ashwagandha, phosphatidylserine) are more effective. Melatonin alone is unlikely to overcome anxiety-related hyperarousal.
Quick answer: Melatonin is not a sedative — it is a circadian signal. Doses of 0.5–1 mg taken 60–90 minutes before bed advance the sleep phase more effectively than the 5–10 mg doses sold in most US supplements. Above 1 mg, melatonin spills into receptor desensitization territory and suppresses endogenous production. For jet lag, shift work, and delayed sleep phase syndrome, melatonin is one of the most effective interventions in sleep medicine — but for garden-variety insomnia, the dose and timing matter more than the supplement itself.
What Melatonin Actually Does in the Body
Melatonin is produced by the pineal gland in response to darkness. The suprachiasmatic nucleus (SCN) in the hypothalamus — the master circadian clock — detects light through ipRGCs (intrinsically photosensitive retinal ganglion cells) containing melanopsin. When light hits the retina, it signals the SCN to suppress melatonin synthesis. When darkness falls, suppression lifts and melatonin rises, beginning 2–3 hours before natural sleep onset. This is called dim-light melatonin onset (DLMO), and it is the most precise marker of circadian phase.
Melatonin does not cause sleepiness in the way that antihistamines or benzodiazepines do. It does not act on GABA receptors. It acts primarily on MT1 and MT2 melatonin receptors in the SCN, where it suppresses the wake-promoting “circadian alerting signal” that opposes sleep pressure. Think of it as lowering the alertness set point, not hitting a sleep switch. This distinction explains why melatonin works poorly for people who simply cannot fall asleep due to anxiety or racing thoughts — those require GABA-pathway or cortisol interventions.
The downstream consequences of melatonin extend well beyond sleep. MT1 and MT2 receptors are expressed in the gastrointestinal tract, immune cells, pancreatic beta cells, cardiovascular tissue, and bone. Melatonin is a potent antioxidant (both direct radical scavenging and indirect via stimulating SOD, catalase, and glutathione peroxidase). The gut produces 400 times more melatonin than the pineal gland — primarily via enterochromaffin cells — where it regulates motility and intestinal immune tolerance.
The Dosing Problem: Why 10 mg Is Almost Always Wrong
The US melatonin market is dominated by 5 and 10 mg tablets. These doses are 10–50 times higher than the physiological range needed to shift circadian phase. Endogenous melatonin peaks at approximately 50–150 pg/mL in serum. A 0.3 mg dose of exogenous melatonin achieves supra-physiological levels of 200–500 pg/mL — already well above the natural peak. A 10 mg dose achieves levels 10–40 times higher than the natural peak, with no additional circadian phase-advancing effect and substantial next-day receptor downregulation.
The seminal dose-response study by Lewy et al. (1992, published in Chronobiology International) found that 0.5 mg was sufficient to phase-advance the circadian clock and that higher doses did not produce greater phase-shifting. A 2014 meta-analysis by Ferracioli-Oda et al. in PLOS ONE analyzed 19 RCTs (n=1,683) and found melatonin reduced sleep onset latency by 7.1 minutes and increased total sleep time by 8.3 minutes — effects that were consistent regardless of dose above 0.3 mg.
The practical implication: start with 0.5–1 mg. For circadian rhythm disorders (jet lag, shift work, delayed sleep phase), 0.5–3 mg taken at the strategically correct time is standard. Higher doses may be appropriate for specific conditions under clinical supervision — but for self-directed supplementation, the commonly available 5–10 mg doses are pharmacologically excessive and may suppress endogenous production over time.
Melatonin for Specific Conditions: Where the Evidence Is Strong
Jet Lag
Jet lag is the mismatch between internal circadian time and local solar time after rapid transmeridian travel. It is the single best-evidenced indication for melatonin. A Cochrane review of 10 RCTs found melatonin (0.5–5 mg taken at bedtime at the destination) significantly reduced jet lag symptoms compared to placebo, with faster adaptation particularly for eastward travel (which requires phase advance — moving circadian time earlier, which melatonin uniquely facilitates).
Protocol: for eastward travel across 5+ time zones, take 0.5–3 mg at 10 PM local destination time starting on the day of travel. Continue for 2–4 nights. For westward travel, melatonin is less essential but can help if sleep onset is difficult at the new local bedtime. Light exposure (ideally outdoor morning sunlight) at the destination is equally important — melatonin and light work synergistically to anchor the new circadian phase.
Delayed Sleep Phase Syndrome (DSPS)
DSPS is a circadian rhythm disorder where the entire sleep-wake cycle is phase-delayed — the patient naturally falls asleep at 2–4 AM and wakes at 10 AM–12 PM, feeling perfectly rested on this schedule but unable to fall asleep “on time.” It affects an estimated 0.17% of adults and is heavily genetic (CLOCK gene variants). It is often misdiagnosed as insomnia or depression.
For DSPS, melatonin taken 5–6 hours before the desired sleep time (often around 8–9 PM) phase-advances the circadian clock by approximately 1–1.5 hours per day when combined with bright light exposure in the morning (10,000 lux for 30 minutes at the target wake time). The combination of evening melatonin plus morning bright light is far more effective than either alone, with complete DLMO normalization in 3–6 weeks in most patients.
Shift Work Sleep Disorder
Shift workers who work nights have 40% higher rates of cardiovascular disease, 30% higher rates of metabolic syndrome, and significantly elevated cancer risk — all related to chronic circadian disruption rather than sleep quantity alone. Melatonin taken before daytime sleep (after a night shift) improves daytime sleep duration by approximately 24 minutes per the best available meta-analyses — a modest but consistent benefit. Blackout curtains and avoiding light exposure during the commute home (blue-light blocking glasses) amplify the melatonin effect.
Insomnia in Older Adults
Melatonin production declines approximately 50% between ages 40 and 70, with the DLMO signal also blunting with age. The reduction is partly due to pineal gland calcification, reduced B6 cofactor status (B6 is required for serotonin-to-melatonin conversion), and increased light sensitivity of the MT receptors. For adults over 60 with insomnia, prolonged-release melatonin (PR-melatonin, 2 mg) — which mimics the extended nocturnal melatonin profile — has the strongest evidence: a Cochrane review found PR-melatonin significantly improved sleep quality, reduced sleep onset latency, and was well-tolerated without next-day impairment or withdrawal effects.
The Light Exposure Framework: What Controls Melatonin More Than Supplements
The most powerful melatonin intervention is not a supplement — it is light management. Blue wavelength light (460–480 nm) maximally suppresses melatonin via melanopsin activation in ipRGCs. Typical indoor lighting at night delivers 10–50 lux; smartphones and computer screens deliver 50–500 lux of heavily blue-shifted light. Exposure to even 8 lux of light containing blue wavelengths in the 2–3 hours before bed measurably delays melatonin onset.
The practical protocol for melatonin optimization without supplementation: bright light exposure within 30 minutes of waking (outdoor is best; 10,000 lux light box if outdoor is not available), no overhead fluorescent or cool-white LED light after 9 PM, amber-spectrum bulbs or candlelight in the bedroom, and no screen use within 60 minutes of target sleep time (or blue-light blocking glasses rated to 480 nm). This protocol reliably advances DLMO by 30–90 minutes in people with artificially delayed circadian timing — essentially treating mild DSPS without any supplement.
Sleep deprivation suppresses immune function after just one night — even moderate restriction to 6 hours doubles cold susceptibility. Melatonin production is also directly tied to temperature: the body needs to drop 1–2°F for optimal pineal activation, which is why a cool bedroom (65–68°F) is consistently associated with better sleep quality and higher melatonin output.
Melatonin and Cortisol: The Day-Night See-Saw
Melatonin and cortisol are reciprocally regulated. As melatonin rises in the evening, it suppresses the HPA axis and cortisol secretion. As cortisol rises in the early morning (the cortisol awakening response, or CAR), it suppresses melatonin. This reciprocal relationship means that chronic HPA axis activation — from psychological stress, poor diet, or insufficient sleep — directly suppresses melatonin production and delays sleep onset.
The most common cause of difficulty falling asleep at 10–11 PM with an overactive mind is elevated evening cortisol — not melatonin deficiency. In this context, taking 5 mg melatonin will not overcome elevated cortisol activity. The correct intervention is cortisol-lowering (ashwagandha KSM-66, phosphatidylserine, magnesium glycinate) combined with the light management protocol above. Melatonin supplementation then works far better against a lower cortisol background.
The Complete Sleep Supplement Stack: Beyond Melatonin
Melatonin addresses circadian timing. For sleep architecture (specifically slow-wave sleep depth and REM quality), the following compounds have the strongest evidence:
Magnesium glycinate (300–400 mg, 60 minutes before bed): Magnesium is a cofactor for GABA-A receptor function and directly inhibits NMDA receptors, producing the quiet-nervous-system effect required for sleep onset. A 2012 RCT of 46 older adults found magnesium supplementation significantly improved sleep efficiency, sleep time, and early morning awakening scores versus placebo. It also reduces cortisol and elevates melatonin levels — addressing two upstream drivers simultaneously. Glycinate form is preferred (chelated to glycine, itself a glycine receptor agonist with sleep-deepening effects).
L-theanine (200 mg): An amino acid from green tea that increases alpha brain wave activity (associated with relaxed wakefulness) and elevates GABA and glycine. A 2019 RCT found 200 mg L-theanine 60 minutes before bed improved sleep efficiency, sleep quality, and next-morning alertness without sedation. It works via a completely different mechanism than melatonin and stacks well.
Ashwagandha KSM-66 (300–600 mg): The best-evidenced adaptogen for sleep. A 2019 double-blind RCT published in Medicine found KSM-66 significantly improved total sleep time, sleep efficiency, sleep onset latency, and sleep quality versus placebo over 10 weeks. The mechanism is HPA axis suppression (reducing cortisol) combined with triethylene glycol, a specific withanolide shown to induce sleep in animal models via GABA receptor modulation. It also reduces cortisol — the upstream driver of sleep disruption.
Glycine (3–5 g): An amino acid that reduces core body temperature by causing peripheral vasodilation — one of the key physiological triggers for sleep onset. A 2012 Japanese study found 3 g glycine before bed reduced sleep onset latency, improved slow-wave sleep, and reduced daytime sleepiness the following day. Inexpensive (glycine powder, approximately $15–20 for a 3-month supply), tasteless, and safe. This is one of the most underutilized sleep supplements.
Phosphatidylserine (200–400 mg): A phospholipid that blunts ACTH-driven cortisol production and specifically reduces exercise-induced and psychological stress-induced cortisol spikes. Particularly useful for people whose sleep disruption is driven by high cortisol (rumination, anxiety, 3 AM awakenings after stressful days). When chronic stress is activating the HPA axis, no amount of melatonin will fully compensate without cortisol attenuation.
Melatonin Safety: What You Need to Know
Melatonin is exceptionally safe in short-term use. It does not cause respiratory depression (unlike benzodiazepines), has no addiction potential, and produces no withdrawal syndrome. The most common side effects at high doses (5–10 mg) are next-day grogginess (“sleep inertia”), vivid dreams, and mild headache — all dose-dependent and resolved by reducing to 0.5–1 mg.
The long-term safety question is more nuanced. Exogenous melatonin at pharmacological doses may suppress endogenous pineal production — the same feedback mechanism that suppresses any hormone when you supplement it externally. The evidence is inconsistent: some studies show endogenous suppression with chronic high-dose use; others do not. The conservative approach is to use physiological doses (0.5–1 mg) and reserve melatonin for specific circadian applications (jet lag, shift work, occasional sleep schedule correction) rather than nightly indefinite use. For nightly sleep support, the GABA and cortisol-modulating stack above is more appropriate for long-term use.
Drug interactions: melatonin may potentiate the effects of sedative medications and should be used cautiously with anticoagulants (warfarin) due to theoretical interaction with platelet aggregation pathways. Immunosuppressed patients (organ transplant recipients) should consult their physician before using melatonin, as it has documented immunomodulatory effects.
Melatonin in Children: A Special Note
Pediatric melatonin use has increased 530% in the US between 2012 and 2021 (JAMA Pediatrics, 2023). This is concerning for several reasons. Children have robust endogenous melatonin production; most pediatric sleep problems are behavioral (inconsistent bedtime, screen exposure, insufficient physical activity) rather than physiological. The pediatric pineal gland is highly sensitive to exogenous melatonin, and long-term safety data in children is sparse. The 2023 JAMA Pediatrics study found that many pediatric melatonin products contained doses far exceeding the label — one product contained 347% of the labeled dose.
For children with neurodevelopmental conditions (autism spectrum disorder, ADHD) — where melatonin timing mechanisms are genuinely dysregulated — short-term use at pediatric doses (0.5–3 mg) under physician supervision has reasonable evidence. For neurotypical children with sleep difficulties, behavioral sleep interventions (consistent schedule, no screens 60 minutes before bed, cool dark room, sufficient physical activity) should be exhausted before any supplementation.
The Bottom Line
Melatonin is a genuine and effective circadian intervention — but it is widely misused. The 5–10 mg doses that dominate the US market are pharmacologically excessive; 0.5–1 mg is the evidence-based starting dose for phase-shifting. The best use cases are jet lag, shift work adaptation, delayed sleep phase syndrome, and age-related melatonin decline in adults over 55. For general sleep quality, addressing light exposure, cortisol dysregulation, and magnesium status will outperform melatonin supplementation in most people.
Sleep is the single highest-leverage health intervention available. A night of 7–9 hours with proper sleep architecture — specifically adequate slow-wave sleep and REM cycling — restores immune function, consolidates memory, clears amyloid from the brain via the glymphatic system, and resets the HPA axis for the following day. No supplement fully compensates for structural sleep disruption. If you have persistent difficulty sleeping despite implementing these strategies, contact our office at (810) 206-1402 for a full sleep and circadian assessment.
Frequently Asked Questions
What is the best dose of melatonin for sleep?
For circadian phase-shifting (jet lag, DSPS, shift work), 0.5–1 mg taken 60–90 minutes before the desired bedtime is the evidence-based dose. For older adults with insomnia, prolonged-release melatonin 2 mg has the strongest clinical trial data. The 5–10 mg doses sold in most US supplements are pharmacologically excessive — they do not produce greater sleep benefit than 1 mg but increase next-day grogginess and may suppress endogenous production with chronic use.
Can you take melatonin every night?
Short-term nightly use (2–4 weeks) is safe and well-tolerated. For long-term nightly use, the evidence is limited. The conservative approach is to use melatonin for specific circadian applications (jet lag, schedule correction) and use a GABA/cortisol-modulating stack (magnesium glycinate, L-theanine, ashwagandha) for ongoing sleep support. There is no strong evidence of harm with chronic low-dose (0.5–1 mg) use, but high-dose chronic use may suppress endogenous production.
Why do I wake up at 3 AM even after taking melatonin?
3 AM awakening is a classic sign of premature cortisol surge — the HPA axis activating hours before it should, typically triggered by overnight blood sugar dropping (cortisol is a counter-regulatory hormone), chronic stress, gut dysbiosis, or HPA axis hyperactivity. Melatonin addresses sleep onset but does not prevent cortisol-driven early awakenings. The correct intervention is phosphatidylserine before bed, stable blood sugar overnight (avoid alcohol, eat a small protein snack if needed), and addressing the upstream stress load.
Does melatonin help with anxiety?
Melatonin has mild anxiolytic effects via MT1 receptor activity in the amygdala and suppression of the circadian alerting signal. However, for anxiety-driven sleep disruption, direct GABA modulators (L-theanine, magnesium glycinate) and cortisol-attenuating agents (ashwagandha, phosphatidylserine) are more effective. Melatonin alone is unlikely to overcome anxiety-related hyperarousal.
Dive Deeper
- Sleep Deprivation and Chronic Disease: What Happens to Your Body
- Sleep Optimization: The Science of Deep Sleep and Circadian Rhythms
- Why You Can’t Sleep: Cortisol, HPA Axis Dysfunction, and the Fix
- Sleep Optimization for Longevity: The Science of Better Sleep
- The Glymphatic System: How Your Brain Detoxifies During Sleep
See Also
- Sleep Medicine: Glymphatic System, Circadian Biology, CBT-I, and Sleep Apnea
- Longevity & the Hallmarks of Aging: Senolytics, NAD+, mTOR, and Biological Age
- Longevity Medicine: Senolytics, NAD+, mTOR, Rapamycin, and the Hallmarks of Aging
- Hormesis: Sauna, Cold Therapy, Exercise, and Fasting for Longevity